Citation Impact
Citing Papers
Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice
2009
1400W Is a Slow, Tight Binding, and Highly Selective Inhibitor of Inducible Nitric-oxide Synthase in Vitro and in Vivo
1997
Achondroplasia
2007
The FGF family: biology, pathophysiology and therapy
2009 Standout
Trypanosoma cruzi Contains Major Pyrophosphate Stores, and Its Growth in Vitro and in Vivo Is Blocked by Pyrophosphate Analogs
1999
Glutamate uptake
2001 Standout
Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases
2004 Standout
The Nerve of Glaucoma!
1994
Calcium dependency of n-methyl-d-aspartate toxicity in slices from the immature rat hippocampus
1989
Excitatory amino acids and neuropsychiatrie disorders
1989
The optic nerve head as a biomechanical structure: a new paradigm for understanding the role of IOP-related stress and strain in the pathophysiology of glaucomatous optic nerve head damage
2004 Standout
Reaching a Genetic and Molecular Understanding of Skeletal Development
2002 Standout
Evidence that the Loss of the Voltage‐Dependent Mg2+ Block at the N‐Methyl‐D‐Aspartate Receptor Underlies Receptor Activation During Inhibition of Neuronal Metabolism
1992
Cellular signaling and factors involved in Müller cell gliosis: Neuroprotective and detrimental effects
2009 Standout
Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification
1999
Id Genes Are Direct Targets of Bone Morphogenetic Protein Induction in Embryonic Stem Cells
1999
Skeletal remodeling in health and disease
2007 Standout
Nitric oxide synthases: structure, function and inhibition
2001 Standout
Interaction of the fluorescent probe RH421 with ribulose-1,5-bisphosphate carboxylase/oxygenase and with Na+,K+-ATPase membrane fragments
1996 StandoutNobel
The Epidemiology of Distal Radius Fractures
2012 Standout
Fibroblast growth factor signalling: from development to cancer
2010 Standout
Cellular and molecular mechanisms of action of bisphosphonates
2000
BMP Induction of Id Proteins Suppresses Differentiation and Sustains Embryonic Stem Cell Self-Renewal in Collaboration with STAT3
2003 Standout
Root Canal Irrigants
2006 Standout
Excitotoxic cell death
1992 Standout
Mosaicism of activatingFGFR3 mutations in human skin causes epidermal nevi
2006
Overview of bisphosphonates
1997
Bisphosphonates Act Directly on the Osteoclast to Induce Caspase Cleavage of Mst1 Kinase during Apoptosis
1999
Osteoclast differentiation and activation
2003 StandoutNature
A review of MRI findings in schizophrenia
2001 Standout
Bisphosphonate-Induced Exposed Bone (Osteonecrosis/Osteopetrosis) of the Jaws: Risk Factors, Recognition, Prevention, and Treatment
2005 Standout
Carbonic anhydrase II is an AP‐1 target gene in osteoclasts
2001
Müller cells in the healthy and diseased retina
2006 Standout
Cloned Glutamate Receptors
1994 Standout
Tumour-associated macrophages as treatment targets in oncology
2017 Standout
Bisphosphonates: The first 40years
2011
The Localization of Thyroid Hormone Receptor mRNAs in Human Bone
2000
TGF-β and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease
2016 Standout
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
1994 Standout
Bisphosphonates: mechanisms of action.
1996
Retinal ischemia: mechanisms of damage and potential therapeutic strategies
2004
Dual actions of nitric oxide inN-methyl-d-aspartate receptor-mediated neurotoxicity in cultured retinal neurons
1996
Mutant fibroblast growth factor receptor 3 induces intracellular signaling and cellular transformation in a cell type- and mutation-specific manner
2009
Induction and Activation of the Transcription Factor NFATc1 (NFAT2) Integrate RANKL Signaling in Terminal Differentiation of Osteoclasts
2002 Standout
Selective pharmacological inhibition of distinct nitric oxide synthase isoforms
1996
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Bisphosphonates: from the laboratory to the clinic and back again
1999
The Fibroblast Growth Factor signaling pathway
2015 Standout
Direct incorporation of unprotected ketone groups into peptides during solid-phase synthesis: Application to the one-step modification of peptides with two different biophysical probes for FRET
1998 StandoutNobel
Receptors for Purines and Pyrimidines
1998 Standout
A Critical Review on Chagas Disease Chemotherapy
2002 Standout
Rapid glutamatergic alterations in the neural retina induced by retinal detachment.
2000
Ecto‐enzymes and metabolism of extracellular ATP
1994
Glutamine synthetase protects against neuronal degeneration in injured retinal tissue
1997
Bone Resorption by Osteoclasts
2000 StandoutScience
Different abilities of the four FGFRs to mediate FGF-1 translocation are linked to differences in the receptor C-terminal tail
2006
Osteoclastogenesis, Bone Resorption, and Osteoclast-Based Therapeutics
2003
Autonomous in Vitro Anticancer Drug Release from Mesoporous Silica Nanoparticles by pH-Sensitive Nanovalves
2010 StandoutNobel
Reversible changes in the fluorescence energy transfer accompanying formation of reaction intermediates in probe-labeled (Na+,K+)-ATPase
1993
Physiological and Molecular Basis of Thyroid Hormone Action
2001 Standout
Regulation of Osteoclast Function
1997
Metastatic bone disease: clinical features, pathophysiology and treatment strategies
2001 Standout
Synthesis and Structure−Activity Relationships of Bafilomycin A1 Derivatives as Inhibitors of Vacuolar H+-ATPase
1998
Pharmacological and immunohistochemical evidence for a functional nitric oxide synthase system in rat peritoneal eosinophils
1997 StandoutNobel
Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis*
2000 Standout
Partial reactions of the Na,K-ATPase: determination of rate constants.
1994
Binding of sodium ions and cardiotonic steroids to native and selectively trypsinized Na,K pump, detected by charge movements.
1994
A faulty negative feedback control underlies the schizophrenic syndrome?
1991 StandoutNobel
The inhibitory anti-FGFR3 antibody, PRO-001, is cytotoxic to t(4;14) multiple myeloma cells
2006
Receptors for Purines and Pyrimidines
2012 Standout
Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families
1999 Standout
Cellular and molecular mechanisms of action of bisphosphonates
2000
Excitotoxicity and N‐methyl‐D‐Aspartate receptors
1989
American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update
2014 Standout
Bisphosphonates: Mechanisms of Action
1998
Works of Peer David being referenced
Involvement of excitatory neurotransmitters in the damage produced in chick embryo retinas by anoxia and extracellular high potassium
1988
Structure—activity relations of amiloride derivatives, acting as antagonists of cation binding on Na+/K+-ATPase
1993
The catalytic cycle of the vacuolar H(+)-ATPase. Comparison of proton transport in kidney- and osteoclast-derived vesicles.
1994
The bisphosphonate tiludronate is a potent inhibitor of the osteoclast vacuolar H+-ATPase
1996
Effects of competitive sodium-like antagonists on Na,K-ATPase suggest that cation occlusion from the cytoplasmic surface occurs in two steps
1993
Differential Activation of Cysteine-Substitution Mutants of Fibroblast Growth Factor Receptor 3 Is Determined by Cysteine Localization
2002
Guanidinium derivatives act as high affinity antagonists of Na+ ions in occlusion sites of Na+,K(+)-ATPase.
1992
Characterization of lanthanides as competitors of Na+ and K+ in occlusion sites of renal (Na+,K+)-ATPase
1991
Section Review: Oncologic, Endocrine & Metabolic: The vacuolar H+-ATPase: A potential target for drug development in bone diseases
1995